Insider · CIK 0002062139

Duncan McKechnie

officer

Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Feb 26, 2026, latest Mar 13, 2026.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

0 / 3

$0 bought, $4.9M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VRTX: VERTEX PHARMACEUTICALS INC / MA

VRTXOct 9, 2026 · close 510.08

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
40Moderate	VRTXsell 810b5-1 VERTEX PHARMACEUTICALS INC / MA	$1.3M 2,633 shares	-17%	+34% from low-4% from high	Mar 13, 2026
40Moderate	VRTXsell 810b5-1 VERTEX PHARMACEUTICALS INC / MA	$1.2M 2,437 shares	-14%	+30% from low-7% from high	Mar 6, 2026
40Moderate	VRTXsell 910b5-1 VERTEX PHARMACEUTICALS INC / MA	$2.4M 4,910 shares	-22%	+32% from low-6% from high	Feb 26, 2026

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Mar 11, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	SOpen-market sale Common Stock10b5-1	-2,633	$498.42	$1.3M	12,489	Mar 13, 2026
Mar 4, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	SOpen-market sale Common Stock10b5-1	-2,437	$475.30	$1.2M	15,122	Mar 6, 2026
Feb 24, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock10b5-1	-873	$485.11	$424k	22,469	Feb 26, 2026
Feb 25, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	SOpen-market sale Common Stock10b5-1	-2,500	$486.35	$1.2M	19,969	Feb 26, 2026
Feb 25, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	SOpen-market sale Common Stock10b5-1	-2,410	$489.00	$1.2M	17,559	Feb 26, 2026
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	AGrant or award Common Stock	+4,962	$0.00	$0	24,490	Feb 19, 2026
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-1,148	$483.75	$555k	23,342	Feb 19, 2026
Feb 13, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-2,283	$487.76	$1.1M	19,528	Feb 18, 2026
Feb 10, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-1,127	$468.41	$528k	21,811	Feb 12, 2026
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	AGrant or award Common Stock	+4,720	$0.00	$0	20,858	Jan 26, 2026
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	AGrant or award Common Stock	+2,080	$0.00	$0	22,938	Jan 26, 2026

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.